Editas Medicine (EDIT) Assets Average (2016 - 2025)
Editas Medicine (EDIT) has disclosed Assets Average for 10 consecutive years, with $206.2 million as the latest value for Q3 2025.
- Quarterly Assets Average fell 42.12% to $206.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $206.2 million through Sep 2025, down 42.12% year-over-year, with the annual reading at $420.4 million for FY2024, 17.04% down from the prior year.
- Assets Average for Q3 2025 was $206.2 million at Editas Medicine, down from $237.1 million in the prior quarter.
- The five-year high for Assets Average was $768.1 million in Q2 2021, with the low at $206.2 million in Q3 2025.
- Average Assets Average over 5 years is $502.4 million, with a median of $503.0 million recorded in 2023.
- The sharpest move saw Assets Average surged 38.67% in 2021, then tumbled 42.53% in 2025.
- Over 5 years, Assets Average stood at $697.3 million in 2021, then dropped by 25.04% to $522.7 million in 2022, then fell by 3.97% to $501.9 million in 2023, then plummeted by 33.34% to $334.6 million in 2024, then crashed by 38.38% to $206.2 million in 2025.
- According to Business Quant data, Assets Average over the past three periods came in at $206.2 million, $237.1 million, and $302.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.